Features Filings buzz in pharma: 15% decrease in internet of things mentions in Q2 2022 Comment Complete responses reported for Nkarta’s off-the-shelf NK cell therapies
Comment Biopharmaceutical Manufacturing Success Strategies with Contract Manufacturing Organizations kgi-admin
News Can-Fite BioPharma to initiate Phase III trial of piclidenoson to treat rheumatoid arthritis admin